Showing results (111-120 of 134) with videos related to
Sort By:
Pageof 14
Reproductive Sciences (Thousand Oaks, Calif.)|September 1, 2017
An Embryonic and Induced Pluripotent Stem Cell Model for Ovarian Granulosa Cell Development and SteroidogenesisShane Lipskind, Jennifer S Lindsey, Behzad Gerami-Naini, et al.Proceedings of the National Academy of Sciences of the United States of America|November 1, 2013
Structures of intermediate transport states of ZneA, a Zn(II)/proton antiporterJohn Edward Pak, Elisabeth Ngonlong Ekendé, Efrem G Kifle, et al.Addiction (Abingdon, England)|December 20, 2011
Collaborative behavioral management among parolees: drug use, crime and re-arrest in the Step'n Out randomized trialPeter D Friedmann, Traci C Green, Faye S Taxman, et al.Cancer|December 29, 2015
SARC009: Phase 2 study of dasatinib in patients with previously treated, high-grade, advanced sarcomaScott M Schuetze, J Kyle Wathen, David R Lucas, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 3, 2009
Report from the Radiation Therapy Committee of the Southwest Oncology Group (SWOG): Research Objectives Workshop 2008Paul Okunieff, Lisa A Kachnic, Louis S Constine, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2008
Phase III randomized, intergroup trial assessing imatinib mesylate at two dose levels in patients with unresectable or metastatic gastrointestinal stromal tumors expressing the kit receptor tyrosine kinase: S0033Charles D Blanke, Cathryn Rankin, George D Demetri, et al.JAMA Oncology|February 15, 2017
Correlation of Long-term Results of Imatinib in Advanced Gastrointestinal Stromal Tumors With Next-Generation Sequencing Results: Analysis of Phase 3 SWOG Intergroup Trial S0033Michael C Heinrich, Cathryn Rankin, Charles D Blanke, et al.JAMA Oncology|May 1, 2018
Association of Dasatinib With Progression-Free Survival Among Patients With Advanced Gastrointestinal Stromal Tumors Resistant to ImatinibScott M Schuetze, Vanessa Bolejack, Dafydd G Thomas, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 26, 2011
R1507, a monoclonal antibody to the insulin-like growth factor 1 receptor, in patients with recurrent or refractory Ewing sarcoma family of tumors: results of a phase II Sarcoma Alliance for Research through Collaboration studyAlberto S Pappo, Shreyaskumar R Patel, John Crowley, et al.Proceedings of the National Academy of Sciences of the United States of America|November 10, 2012
Unique motifs and hydrophobic interactions shape the binding of modified DNA ligands to protein targetsDouglas R Davies, Amy D Gelinas, Chi Zhang, et al.Pageof 14